Telix Pharmaceuticals (Australia) Price on July 22, 2024
| TLX Stock | 24.62 0.12 0.49% |
Below is the normalized historical share price chart for Telix Pharmaceuticals extending back to November 15, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Telix Pharmaceuticals stands at 24.62, as last reported on the 24th of December, with the highest price reaching 25.02 and the lowest price hitting 24.35 during the day.
If you're considering investing in Telix Stock, it is important to understand the factors that can impact its price. Telix Pharmaceuticals appears to be very steady, given 3 months investment horizon. Telix Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.18, which indicates the firm had a 0.18% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Telix Pharmaceuticals, which you can use to evaluate the volatility of the company. Please review Telix Pharmaceuticals' Risk Adjusted Performance of 0.1216, coefficient of variation of 684.98, and Semi Deviation of 1.82 to confirm if our risk estimates are consistent with your expectations.
At this time, Telix Pharmaceuticals' Total Stockholder Equity is comparatively stable compared to the past year. Common Stock Total Equity is likely to gain to about 201.7 M in 2024, whereas Capital Stock is likely to drop slightly above 246.2 M in 2024. . Telix Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 18.6486 | 50 Day MA 23.0988 | Beta 2.384 |
Telix |
Sharpe Ratio = 0.1765
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TLX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.89 actual daily | 16 84% of assets are more volatile |
Expected Return
| 0.33 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.18 actual daily | 13 87% of assets perform better |
Based on monthly moving average Telix Pharmaceuticals is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Telix Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 20.3996 | Enterprise Value Ebitda 111.6167 | Price Sales 12.8876 | Shares Float 282.3 M | Wall Street Target Price 25.6159 |
Related Headline
Flagship Investments Headline on 22nd of July 2024
Nvidia developing flagship AI chip for Chinese market- Reute... by news.google.com
Nvidia developing flagship AI chip for Chinese market- Reuters Investing.com
Telix Pharmaceuticals Valuation on July 22, 2024
It is possible to determine the worth of Telix Pharmaceuticals on a given historical date. On July 22, 2024 Telix was worth 19.2 at the beginning of the trading date compared to the closed value of 19.63. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Telix Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Telix Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Telix Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Telix Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 19.41 | 19.46 | 18.81 | 19.13 | 6,335,507 | |
07/22/2024 | 19.20 | 19.66 | 19.15 | 19.63 | 1,022,296 |
| 20.22 | 20.43 | 19.94 | 20.31 | 1,964,627 |
| Backtest Telix Pharmaceuticals | | | Telix Pharmaceuticals History | | | Telix Pharmaceuticals Valuation | Previous | Next |
Telix Pharmaceuticals Trading Date Momentum on July 22, 2024
| On July 23 2024 Telix Pharmaceuticals was traded for 20.31 at the closing time. The maximum traded price for the trading interval was 20.43 and the lowest daily price was 19.94 . The daily volume was recorded at 2 M. The volume of trading on 23rd of July 2024 played a part in the next trading day price appreciation. The trading price change to the next closing price was 3.46% . The trading price change to the closing price today is 1.68% . |
Telix Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Telix Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Telix Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Telix financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Telix Pharmaceuticals Stock history
Telix Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Telix is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Telix Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Telix Pharmaceuticals stock prices may prove useful in developing a viable investing in Telix Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 323.7 M | 221.8 M | |
| Net Loss | -93.7 M | -89 M |
Telix Pharmaceuticals Quarterly Net Working Capital |
|
Telix Pharmaceuticals Stock Technical Analysis
Telix Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Telix Pharmaceuticals Period Price Range
Low | December 24, 2024
| High |
0.00 | 0.00 |
Telix Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on Australian Securities Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Telix Pharmaceuticals December 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Telix Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Telix Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Telix Pharmaceuticals stock market strength indicators, traders can identify Telix Pharmaceuticals entry and exit signals to maximize returns
Telix Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Telix Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Telix Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Telix to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1216 | |||
| Jensen Alpha | 0.2715 | |||
| Total Risk Alpha | 0.2157 | |||
| Sortino Ratio | 0.122 | |||
| Treynor Ratio | 8.33 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Telix Stock Analysis
When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.